Back to search
FDAFDA · Food and drugs·Recall number D-023-2014

Morphine Sulfate Injection, USP, (25mg/mL), 250 mg, 10mL Fill, Single dosage Flip top Vial, (C-II), (NDC 0409-1135-02), Rx Only, Manfactured for Hospira, Inc., Lake Forest, IL 60045 USA.

Published December 11, 2013 · Recall initiated: September 16, 2013

Summary

FDA records drug Class II recall D-023-2014, published December 11, 2013 and initiated September 16, 2013. Recalling firm: Hospira, Inc.; Status: Terminated; Reported quantity: 29,700 vials; Lot: Lot #17368EV Exp 08/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Confirmed customer report of leakage of vial contents due to the breaking of the vial neck.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira, Inc.
Distributor
Nationwide
Lot
Lot #17368EV Exp 08/13
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Morphine Sulfate Injection, USP, (25mg/mL), 250 mg, 10mL Fill, Single dosage Flip top Vial, (C-II), (NDC 0409-1135-02), Rx Only, Manfactured for Hospira, Inc., Lake Forest, IL 60045 USA. recalled?

Yes. FDA published recall D-023-2014 on December 11, 2013. Reported hazard: Lack of Assurance of Sterility: Confirmed customer report of leakage of vial contents due to the breaking of the vial neck.

What should I do if I have this product?

Voluntary: Firm initiated · Letter